News
Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
In today’s CEO Daily: Diane Brady talks to Pfizer CEO Albert Bourla about defending science amid a backdrop of political ...
Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...
By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good ...
Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another ...
7hon MSN
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
It is still being sold under emergency use authorization — unlike mRNA vaccines made by Pfizer and Moderna ... of political interference under Robert F. Kennedy Jr., who spent decades leading ...
The U.S. FDA is asking Novavax (NASDAQ:NVAX) to conduct an additional randomized, controlled study of its COVID-19 vaccine ...
Pfizer shows profit growth from cost cuts ... after President Donald Trump's pick for U.S. health secretary, Robert F. Kennedy Jr., moved closer to the job after a favorable vote by a Senate ...
Healthcare & Pharmaceuticalscategory· April 14, 2025 Pfizer ends development of weight ... after Health and Human Services Secretary Robert F. Kennedy Jr. raised concerns about the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results